Ellagic Acid Reverses Alterations in the Expression of AMPA Receptor and Its Scaffolding Proteins in the Cerebral Cortex and Memory Decline in STZ-sporadic Alzheimer’ s Disease Mouse Model-Reference-Cited by-同舟云学术

Ellagic Acid Reverses Alterations in the Expression of AMPA Receptor and Its Scaffolding Proteins in the Cerebral Cortex and Memory Decline in STZ-sporadic Alzheimer’ s Disease Mouse Model

Published:2024-06-06 Issue: Volume: Page:
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Singh Nidhi Anand K.,Prasad S.

Funder

Indian Council of Medical Research

Council for Scientific and Industrial Research, India

Banaras Hindu University

CAS in Zoology, Banaras Hindu University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00213-024-06622-9.pdf

Reference64 articles.

1. Ahmed HA, Ismael S, Mirzahosseini G, Ishrat T (2021) Verapamil prevents development of cognitive impairment in an aged mouse model of sporadic Alzheimer’s Disease. Mol Neurobiol 58(7):3374–3387. https://doi.org/10.1007/s12035-021-02350-9

2. Ardah MT, Bharathan G, Kitada T, Haque ME (2020) Ellagic acid prevents dopamine neuron degeneration from oxidative stress and neuroinflammation in MPTP model of Parkinson’s disease. Biomolecules 10(11):1–17. https://doi.org/10.3390/biom10111519

3. Ardiles ÁO, Tapia-Rojas CC, Mandal M, Alexandre F, Kirkwood A, Inestrosa NC, Palacios AG (2012) Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer’s disease. Proc Natl Acad Sci U S A 21(34):109. https://doi.org/10.1073/pnas.1201209109

4. Ardiles ÁO, Mandal CC, Alexandre M, Kirkwood F A., Inestrosa, N. C., & Palacios, A. G

5. Azumaya CM, Days EL, Vinson PN, Stauffer S, Sulikowski G, Weaver CD, Nakagawa T (2017) Screening for AMPA receptor auxiliary subunit specific modulators. PLoS ONE 12(3):1–23. https://doi.org/10.1371/journal.pone.0174742